HANSAINVEST reports 5.69% stake in Hinge Health

Hinge Health, Inc. investor HANSAINVEST Hanseatische Investment-Limited Co reported beneficial ownership of 2,157,071 ordinary shares, representing 5.69% of the class as of December 31, 2025.

Rhea-AI Filing Summary

Hinge Health, Inc. investor HANSAINVEST Hanseatische Investment-Limited Co reported beneficial ownership of 2,157,071 ordinary shares, representing 5.69% of the class as of December 31, 2025.

The shares are held for investment funds managed by HANSAINVEST, which under German law has sole voting and dispositive power. The position is certified as acquired and held in the ordinary course of business, not to change or influence control of Hinge Health.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake did HANSAINVEST report in Hinge Health (HNGE)?

HANSAINVEST reported beneficial ownership of 2,157,071 ordinary shares of Hinge Health, Inc., representing 5.69% of the outstanding class as of December 31, 2025. This crosses the 5% threshold that requires public disclosure of significant shareholdings.

Who is the reporting person on the Hinge Health (HNGE) Schedule 13G?

The reporting person is HANSAINVEST Hanseatische Investment-Limited Co, a German investment management company (KVG). Director Pascal Reyer signed the statement, providing the Hamburg business address and confirming German citizenship and the firm’s status as a non-U.S. institution.

Does HANSAINVEST control voting and disposition of its Hinge Health shares?

Yes. HANSAINVEST reports sole power to vote and dispose of 2,157,071 Hinge Health ordinary shares, with no shared voting or dispositive power. Under German law, it may exercise ownership rights for investment funds that co-own the shares with underlying investors.

Are HANSAINVEST’s Hinge Health (HNGE) shares held to influence control of the company?

No. HANSAINVEST certifies the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Hinge Health, nor in connection with any transaction intended to have that control-related effect.

In whose accounts are the Hinge Health (HNGE) shares actually held?

The ordinary shares are held for the account of investment funds managed by HANSAINVEST. Under German law, HANSAINVEST is not the legal owner; the investors co-own the shares, while HANSAINVEST retains authority to exercise ownership rights and full dispositive power.

How does HANSAINVEST classify itself for Hinge Health share reporting?

HANSAINVEST classifies itself as a non-U.S. institution, specifically a German KVG (investment management company). It certifies that its foreign regulatory framework is substantially comparable to the U.S. scheme for equivalent institutions and agrees to furnish additional information to the Commission staff upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/29/2026 - 07:18 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Hinge Health, Inc.

(Name of Issuer)

Ordinary Shares

(Title of Class of Securities)

433313103

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

HANSAINVEST Hanseatische Investment-Limited Co

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

GERMANY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,157,071.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,157,071.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,157,071.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.7 %

12

Type of Reporting Person (See Instructions)

OO, FI

Comment for Type of Reporting Person: The shares are held for the account of investment funds managed by HANSAINVEST. Under German law HANSAINVEST is not the legal owner of these shares which are co-owned by the investors. However by operation of German law (Sec. 93 (1) KAGB) HANSAINVEST is authorized to exercise the ownership rights to vote the shares and has full dipositive power over the shares. The ownership information above is as of 31th of December 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Hinge Health, Inc.
(b)	Address of issuer's principal executive offices: 455 MARKET STREET, 7TH FLOOR, SAN FRANCISCO, CALIFORNIA, 94105
Item 2.
(a)	Name of person filing: Pascal Reyer
(b)	Address or principal business office or, if none, residence: Kapstadtring 8 22297 Hamburg Germany
(c)	Citizenship: German
(d)	Title of class of securities: Ordinary Shares
(e)	CUSIP No.: 433313103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	German KVG (Investment Management Company)
Item 4.	Ownership
(a)	Amount beneficially owned: 2,157,071.00
(b)	Percent of class: 5.69 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,157,071.00
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,157,071.00
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Investment Management Company (KVG) is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

HANSAINVEST Hanseatische Investment-Limited Co

Signature:	Pascal Reyer
Name/Title:	Director of Reporting
Date:	01/29/2026